Opexa (OPXA) presents Tovaxin® Data
April 15th, 2011
No comments
OPXA presented clinical data highlighting efficacy data from OPXA’s Phase IIb TERMS clinical trial in a sub-population of patients Read more…
Categories: NASDAQ:OPXA, Phase IIb TERMS clinical trial, Stem Cell Research
